Diasorin Spa Stock Five Year Return

34D Stock  EUR 105.20  2.40  2.23%   
DiaSorin SpA fundamentals help investors to digest information that contributes to DiaSorin SpA's financial success or failures. It also enables traders to predict the movement of DiaSorin Stock. The fundamental analysis module provides a way to measure DiaSorin SpA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to DiaSorin SpA stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

DiaSorin SpA Company Five Year Return Analysis

DiaSorin SpA's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.

Five Year Return

 = 

(Mean of Monthly Returns - 1)

X

100%

More About Five Year Return | All Equity Analysis

Current DiaSorin SpA Five Year Return

    
  1.21 %  
Most of DiaSorin SpA's fundamental indicators, such as Five Year Return, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, DiaSorin SpA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
Competition

According to the company disclosure, DiaSorin SpA has a Five Year Return of 1.21%. This is much higher than that of the Healthcare sector and significantly higher than that of the Diagnostics & Research industry. The five year return for all Germany stocks is notably lower than that of the firm.

DiaSorin Five Year Return Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DiaSorin SpA's direct or indirect competition against its Five Year Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of DiaSorin SpA could also be used in its relative valuation, which is a method of valuing DiaSorin SpA by comparing valuation metrics of similar companies.
DiaSorin SpA is currently under evaluation in five year return category among its peers.

DiaSorin Fundamentals

About DiaSorin SpA Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze DiaSorin SpA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DiaSorin SpA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DiaSorin SpA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in DiaSorin Stock

DiaSorin SpA financial ratios help investors to determine whether DiaSorin Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DiaSorin with respect to the benefits of owning DiaSorin SpA security.